SMLR Logo

Semler Scientific, Inc. (SMLR) 

NASDAQ
Market Cap
$572.54M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
116 of 960
Rank in Industry
9 of 120

Largest Insider Buys in Sector

SMLR Stock Price History Chart

SMLR Stock Performance

About Semler Scientific, Inc.

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery …

Insider Activity of Semler Scientific, Inc.

Over the last 12 months, insiders at Semler Scientific, Inc. have bought $1.9M and sold $8.27M worth of Semler Scientific, Inc. stock.

On average, over the past 5 years, insiders at Semler Scientific, Inc. have bought $2.02M and sold $4.79M worth of stock each year.

Highest buying activity among insiders over the last 12 months: SEMLER ERIC (director) — $9.48M.

The last purchase of 50,000 shares for transaction amount of $1.9M was made by SEMLER ERIC (director) on 2024‑11‑07.

List of Insider Buy and Sell Transactions, Semler Scientific, Inc.

2024-12-11SaleCEO
25,000
0.2963%
$62.24$1.56M+11.33%
2024-12-10SaleCEO
75,000
0.9142%
$60.12$4.51M+16.17%
2024-11-07SaleCEO
50,000
0.72%
$37.93$1.9M+61.43%
2024-11-07Purchasedirector
50,000
0.72%
$37.93$1.9M+61.43%
2024-08-29SaleCEO
10,101
0.1497%
$28.34$286,302+3.87%
2024-08-28SaleCEO
780
0.0113%
$28.32$22,087-1.44%
2023-09-13Purchasedirector
26,868
0.3916%
$28.11$755,259+9.95%
2023-09-12Purchasedirector
25,903
0.372%
$27.70$717,513+8.70%
2023-09-11Purchasedirector
25,000
0.3631%
$26.98$674,500+12.84%
2022-02-28SaleChief Executive Officer
2,000
0.0294%
$72.65$145,291-50.36%
2022-02-22SaleChief Executive Officer
2,000
0.0297%
$70.22$140,430-47.49%
2022-02-15SaleChief Executive Officer
2,000
0.0291%
$76.04$152,079-51.87%
2022-02-07SaleChief Executive Officer
2,000
0.0296%
$78.73$157,451-52.22%
2022-02-01SaleChief Executive Officer
2,000
0.0288%
$76.53$153,056-51.47%
2022-01-24SaleChief Executive Officer
2,000
0.0284%
$72.35$144,696-48.78%
2022-01-18SaleChief Executive Officer
2,000
0.0294%
$76.69$153,374-49.50%
2021-10-25SaleChief Executive Officer
1,250
0.0185%
$144.03$180,036-68.58%
2021-10-18SaleChief Executive Officer
1,250
0.0184%
$137.36$171,704-66.92%
2021-10-11SaleChief Executive Officer
1,250
0.0186%
$129.01$161,258-63.74%
2021-10-04SaleChief Executive Officer
1,250
0.0185%
$127.28$159,099-62.85%

Insider Historical Profitability

16.58%
SEMLER ERICdirector
621721
6.7087%
$61.7850
Murphy-Chutorian DouglasCEO
55000
0.5935%
$61.78860<0.0001%
Chang William H10 percent owner
965306
10.4161%
$61.7840<0.0001%
William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/200610 percent owner
412537
4.4515%
$61.78110+268.41%
Collins Aidan Matthewdirector
1100
0.0119%
$61.7820<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Cerity Partners$20.5M9.93701,789+0.09%+$17,701.260.06
The Vanguard Group$9.33M4.52319,414-3.78%-$366,965.23<0.0001
BlackRock$9.06M4.39310,252-3.59%-$337,404.71<0.0001
LSV Asset Management$7.39M3.58252,887+58.02%+$2.71M0.02
Acadian Asset Management$4.84M2.35165,876+68.24%+$1.96M0.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.